Product Development Pipeline
Inventa Therapeutics's early-stage development pipeline currently has multiple new molecular entities in pre-clinical development in the following therapeutic focus areas: rare diseases and neuroscience.
| Therapeutic Area | Product Candidate | Indication | Discovery Preclinical Phase1 Phase 2 Phase 3 |
|---|---|---|---|
| Inflammation | IVT-101 | Ulcerative Colitis |  |
| IVT-102 | Psoriasis | |
|
| IVT-103 | Atopic Dermatitis | |
|
| Oncology | IVT-201 | Ovarian Cancer | |
| IVT-202 | Hematological Cancer | |
|
| IVT-203 | Breast Cancer | |
|
| IVT-301 | COPD | |
|
| Respiratory | IVT-302 | Cystic Fibrosis | |
| IVT-303 | PAH | |